1 Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL.
2 Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA.
3 Divisions of Infectious Diseases and Organ Transplantation, Transplant and Immunocompromised Host Infectious Diseases Service, Northwestern University Feinberg School of Medicine, Chicago, IL.
Received 13 June 2021. Revision received 8 September 2021.
Accepted 4 October 2021.
This work was supported by National Center for Advanced Translational Science (grant UL1TR001422).
M.G.I. received research support, paid to Northwestern University, from AiCuris, Janssen, and Shire; he is a paid consultant for Adagio, AlloVir, Celltrion, Cidara, Genentech, Roche, Janssen, Shionogi, Takeda, and Viracor Eurofins; he is also a paid member of Data and Safety Monitor Boards from Janssen, Merck, SAB Biotherapeutics, Sequiris, Takeda, and Vitaeris. The other authors declare no conflicts of interest.
O.M.A.-H. participated in the writing and revising of the article. H.P.C. provided relevant images for the article. M.G.I. participated in the writing and revising of the article.
Correspondence: Michael G. Ison, MD, MS, Divisions of Infectious Diseases and Organ Transplantation, Transplant and Immunocompromised Host Infectious Diseases Service, Northwestern University Feinberg School of Medicine, 645 N. Michigan Ave Suite 900, Chicago, IL 60611. ([email protected]).